NCT02752880View on ClinicalTrials.gov

YH1 in Poorly Controlled Type 2 Diabetes

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Type 2 Diabetes
Interventions
DRUG

YH1 group

Participants were randomly assigned 1:1 to receive either YH1 or placebo for 12 consecutive weeks.

DRUG

placebo group

Participants were randomly assigned 1:1 to receive either YH1 or placebo for 12 consecutive weeks.

Trial Locations (1)

Unknown

Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT02752880 - YH1 in Poorly Controlled Type 2 Diabetes | Biotech Hunter | Biotech Hunter